Table 1 Demographics of study participants from Mountjoy Prison (March to August 2017)
From: Evaluating peer-supported screening as a hepatitis C case-finding model in prisoners
Variable | Participant numbers | Value n (%) | Mean (SD) |
|---|---|---|---|
Agea, b | 425 | 32.8 (8.9) | |
Age of first incarcerationa | 364 | 20.0 (7.1) | |
Episodes of incarcerationa | 359 | 5.9 (8.3) | |
Total time incarcerated (years)a | 361 | 7.7 (6.6) | |
Age of first drug usea | 281 | 15.4 (7.7) | |
Age of first IV usea | 106 | 20.1 (5.4) | |
Previous drug useb | 409 | 199 (48.7) | |
Shared needlesb | 406 | 26 (6.4) | |
Country of origin (n = 425)b | |||
Ireland | 389 (91.5) | ||
West Europe | 4 (0.9) | ||
East Europe | 22 (5.2) | ||
Africa | 10 (2.4) | ||
HCV acquisition risk factors | |||
History of heroin use | 355 | 161 (45.4) | |
History of IV use | 341 | 111 (32.6) | |
Shared needle community | 342 | 54 (15.8) | |
Shared equipment | 344 | 120 (34.9) | |
Shared razor in prison | 357 | 15 (4.2) | |
Shared toothbrush in prison | 358 | 3 (0.8) | |
Prison tattoo | 358 | 62 (17.3) | |
Unsterile tattoo community | 346 | 49 (14.2) | |
Opioid substitution treatment | |||
Methadone treatment history | 342 | 124 (36.3) | |
Length of time on methadone maintenance treatment | 101 | 4.9 (6.6) | |